MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ANVS has $21,081,625 in assets. $4,230,375 in debts. $19,532,338 in cash and cash equivalents.

Balance Sheets Overview

Cash Ratio
537.29%
Debt to Asset Ratio
20.07%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
19,532,338
Prepaid expenses and other current assets
1,549,287
Total assets
21,081,625
Accounts payable
2,590,516
Accrued expenses
1,044,859
Total current liabilities
3,635,375
Warrant liability
595,000
Total liabilities
4,230,375
Common stock - 0.0001 par value, 70,000,000 shares authorized, 27,199,139 and 14,141,521 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively
2,719
Additional paid-in capital
180,552,190
Accumulated deficit
-163,703,659
Total stockholders' equity
16,851,250
Total liabilities and stockholders' equity
21,081,625
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$19,532,338 Prepaid expenses andother current assets$1,549,287 Total assets$21,081,625 Total liabilities andstockholders' equity$21,081,625 Total stockholders'equity$16,851,250 Total liabilities$4,230,375 Accumulated deficit-$163,703,659 Additional paid-in capital$180,552,190 Total currentliabilities$3,635,375 Warrant liability$595,000 Common stock - 0.0001par value,...$2,719 Accounts payable$2,590,516 Accrued expenses$1,044,859

Annovis Bio, Inc. (ANVS)

Annovis Bio, Inc. (ANVS)